GlassScriptPhysician profile
Russell Phillip Simon
NPI 1518498526
$919.73
in general payments reported to CMS, 2019-2025
16 companies · $534 in 2025
The $534 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.87 · 2022: $109 · 2023: $202 · 2024: $28.01 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $200.27 | 2022-2023 | Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $139.49 | 2025 | Watchman |
| Astellas Pharma US INC | $90.99 | 2022 | |
| Corcept Therapeutics | $74.73 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $68.40 | 2025 | |
| Heartflow, INC. | $58.21 | 2024-2025 | |
| Pfizer INC. | $51.05 | 2025 | |
| Shockwave Medical, INC | $47.87 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $41.87 | 2025 | Camzyos |
| Exact Sciences Corporation | $25.21 | 2025 | Cologuard Collection Kit |
| Baxter Healthcare | $22.87 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Lilly USA, LLC | $22.14 | 2025 | Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $21.84 | 2025 | |
| Amgen INC. | $19.03 | 2023 | Repatha |
| Acella Pharmaceuticals, LLC | $18.07 | 2025 | NP Thyroid 60 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $17.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.